Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Gilch

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|April 4, 2022
Chronic wasting disease - A prion disease through a One Health lensSabine Gilch
International Journal of Molecular Sciences|September 26, 2020
The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like DisordersPearl Cherry, Sabine Gilch
Cellular and Molecular Life Sciences : CMLS|April 28, 2009
Aptamers against prion proteins and prionsSabine Gilch, Hermann M Schätzl
Cell and Tissue Research|March 15, 2023
New developments in prion disease researchSabine Gilch, Hermann M Schätzl
Trends in Molecular Medicine|September 18, 2003
Promising developments bringing prion diseases closer to therapy and prophylaxisSabine Gilch, Hermann M Schätzl
The Journal of Biological Chemistry|November 15, 2002
Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion proteinMax Nunziante, Sabine Gilch, Hermann M Schätzl
Journal of Molecular Biology|June 19, 2007
Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formationSabine Gilch, Claudia Kehler, Hermann M Schätzl
Plos Pathogens|November 3, 2017
Chronic wasting disease: Emerging prions and their potential riskSamia Hannaoui, Hermann M Schatzl, Sabine Gilch
Neural Regeneration Research|October 17, 2018
Peptide aptamer-mediated modulation of prion protein α-cleavage as treatment strategy for prion and other neurodegenerative diseasesAntonia N Klein, Erica Corda, Sabine Gilch
Expert Opinion on Biological Therapy|June 14, 2008
Targeting prion proteins in neurodegenerative diseaseSabine Gilch, Carmen Krammer, Hermann M Schätzl
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|April 4, 2022
Chronic wasting disease - A prion disease through a One Health lensSabine Gilch
International Journal of Molecular Sciences|September 26, 2020
The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like DisordersPearl Cherry, Sabine Gilch
Cellular and Molecular Life Sciences : CMLS|April 28, 2009
Aptamers against prion proteins and prionsSabine Gilch, Hermann M Schätzl
Cell and Tissue Research|March 15, 2023
New developments in prion disease researchSabine Gilch, Hermann M Schätzl
Trends in Molecular Medicine|September 18, 2003
Promising developments bringing prion diseases closer to therapy and prophylaxisSabine Gilch, Hermann M Schätzl
The Journal of Biological Chemistry|November 15, 2002
Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion proteinMax Nunziante, Sabine Gilch, Hermann M Schätzl
Journal of Molecular Biology|June 19, 2007
Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formationSabine Gilch, Claudia Kehler, Hermann M Schätzl
Plos Pathogens|November 3, 2017
Chronic wasting disease: Emerging prions and their potential riskSamia Hannaoui, Hermann M Schatzl, Sabine Gilch
Neural Regeneration Research|October 17, 2018
Peptide aptamer-mediated modulation of prion protein α-cleavage as treatment strategy for prion and other neurodegenerative diseasesAntonia N Klein, Erica Corda, Sabine Gilch
Expert Opinion on Biological Therapy|June 14, 2008
Targeting prion proteins in neurodegenerative diseaseSabine Gilch, Carmen Krammer, Hermann M Schätzl
Pageof 8